The metastatic lesions of FH-RCC had echoes of higher immune infiltration than that of the primary lesions, which included enrichment of T effector cells, immune-related chemokines, and upregulation of expression of PD-L1, TIGIT, and BTLA. This evidence concerns the gene BTLA and renal cell carcinoma.